The β1-2-3-adrenoceptors (ADRB1, ADRB2 and ADRB3) genes encode the β-adrenoceptors, and their variants and/or epigenetic modifications are also associated with a high risk of MetS, leading to a genetic vulnerability during the stress response. The gene discussed is ADRB3; the disease is metabolic syndrome.